FIA
MRNA icon

FNY Investment Advisers’s Moderna MRNA Stock Holding History

FNY Investment Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35
Closed -$4K – 640
2022
Q3 		$4K Buy
+35
New +$5.31K ﹤0.01% 474
2022
Q2 		– Sell
-85
Closed -$14K – 827
2022
Q1 		$14K Buy
+85
New +$14.3K 0.01% 400

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

FNY Investment Advisers's MRNA Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in Moderna (MRNA) in Q2 2026: 10 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #977 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in MRNA as recently as Q3 2025.

FNY Investment Advisers first reported a position in MRNA in Q4 2018 and has held it in 16 quarters since. The position peaked at $559K in Q1 2020. 481 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • FNY Investment Advisers held 10 shares of Moderna worth $0 as of Q2 2026.
  • Moderna was a new FNY Investment Advisers position in Q2 2026.
  • Moderna made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #977 holding.
  • FNY Investment Advisers first reported a position in Moderna in Q4 2018 and has held it in 16 quarters since.
  • FNY Investment Advisers's Moderna position peaked at $559K in Q1 2020.
  • 481 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.